Rankings
▼
Calendar
PRGO FY 2024 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.4B
-6.1% YoY
Gross Profit
$1.5B
35.3% margin
Operating Income
$113M
2.6% margin
Net Income
-$172M
-3.9% margin
EPS (Diluted)
$-1.25
Cash Flow
Operating Cash Flow
$363M
Free Cash Flow
$245M
Stock-Based Comp.
$64M
Balance Sheet
Total Assets
$9.6B
Total Liabilities
$5.3B
Stockholders' Equity
$4.3B
Cash & Equivalents
$559M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.4B
$4.7B
-6.1%
Gross Profit
$1.5B
$1.7B
-8.2%
Operating Income
$113M
$152M
-25.7%
Net Income
-$172M
-$13M
-1252.8%
← Q4 2023
All Quarters
Q1 2024 →